“… 6 These ocular manifestations primarily include conjunctivitis, dry eye disease (DED), meibomian gland dysfunction, keratitis, corneal ulcers, and corneal vascularization. 7 Similar to the pathogenesis of cGVHD damaging other organ systems, T lymphocyte infiltration-derived immunoinflammatory cascade plays a vital role in damaging ocular tissues, including the lacrimal gland, 8 conjunctiva, 9 meibomian gland, 10 cornea, 11 , 12 retina, and optic nerve. 13 The current clinical treatments include artificial tears, corticosteroids, nonspecific immunosuppressants, or surgical interventions with unsatisfactory outcomes.…”